Log out Go to App
Go to App

Learning Materials

Features

Discover

Chapter 44: Problem 15

Glatiramer acetate is an immunomodulatory drug that is FDA approved and clinically indicated for a. amyotrophic lateral sclerosis b. remitting/relapsing multiple sclerosis c. Parkinson's disease d. Alzheimer's disease e. Huntington's disease

Short Answer

Expert verified
a. Amyotrophic lateral sclerosis b. Remitting/relapsing multiple sclerosis c. Parkinson's disease d. Alzheimer's disease e. Huntington's disease

Step by step solution

01

Research Glatiramer Acetate

Look up information about Glatiramer acetate, its mechanism of action, and its FDA-approved indications. This can be done by searching medical literature, textbooks, or reliable online sources.
02

Compare Indications

Based on the information gathered in Step 1, compare Glatiramer acetate's approved indications with the options provided in the question: a. amyotrophic lateral sclerosis, b. remitting/relapsing multiple sclerosis, c. Parkinson's disease, d. Alzheimer's disease, and e. Huntington's disease.
03

Identify the Correct Answer

From the comparison made in Step 2, determine which option is the correct clinical indication for Glatiramer acetate among the multiple-choice options provided. Answer: b. remitting/relapsing multiple sclerosis

Unlock Step-by-Step Solutions & Ace Your Exams!

  • Full Textbook Solutions

    Get detailed explanations and key concepts

  • Unlimited Al creation

    Al flashcards, explanations, exams and more...

  • Ads-free access

    To over 500 millions flashcards

  • Money-back guarantee

    We refund you if you fail your exam.

Start your free trial

Over 30 million students worldwide already upgrade their learning with Vaia!

One App. One Place for Learning.

All the tools & learning materials you need for study success - in one app.

Get started for free

Most popular questions from this chapter

A ligand utilized for in vivo imaging of reactive microglia via upregulated peripheral benzodiazepine receptors is a. CFT b. DA c. GTlb d. MPTP e. PK 1195

An example of free radical modification of RNA is a. 8-hydroxyguanosine (8-OHG) b. 4-hydroxy-2-nonenal (HNE) c. 3-nitrotyrosine (NT) d. 8-hydroxy-2'-deoxyguanosine (8-OHdG)

The possible mechanism by which glatiramer acetate functions is a. competition with myelin-basic protein (MBP) for binding to major histocompatibility complex (MHC) molecules b. competition of GA/MHC with MBP/MHC for binding to the T-cell receptor c. partial activation and tolerance induction of MBP-specific T cells d. induction of GA-reactive T-helper 2- (TH2)-like regulatory cells e. all of the above

Regulatory T cells capable of attenuating microglial responses are more likely to produce and secrete a. IL-10 b. \(\mathrm{IL}-2\) c. IFN- \(\gamma\) d. \(\mathrm{TNF}-\alpha\)

The cellular target for immunotherapy that would be most beneficial to inhibit secondary neurodegeneration is the a. astrocyte b. neuron c. microglia d. oligodentrocyte
See all solutions

Recommended explanations on Biology Textbooks

Cell Cycle

Read Explanation

Cells

Read Explanation

Plant Biology

Read Explanation

Ecological Levels

Read Explanation

Reproduction

Read Explanation

Heredity

Read Explanation
View all explanations

What do you think about this solution?

We value your feedback to improve our textbook solutions.

Study anywhere. Anytime. Across all devices.

Sign-up for free